Evidence map›Paper›PMID 36347306›Full record

ArticleJournal of theoretical biology2023

Ascertainment rate of SARS-CoV-2 infections from healthcare and community testing in the UK.

Ewan Colman, Gavrila A Puspitarani, Jessica Enright, Rowland R Kao

Abstract read
In one paragraph

Article in Journal of theoretical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ewan ColmanRoyal (Dick) School of Veterinary Studies and the Roslin Institute, University of Edinburgh, Midlothian, UK.
Gavrila A PuspitaraniRoyal (Dick) School of Veterinary Studies and the Roslin Institute, University of Edinburgh, Midlothian, UK; Unit Veterinary Public Health and Epidemiology, University of Veterinary Medicine, Vienna, Austria; Complexity Science Hub Vienna, Austria.
Jessica EnrightSchool of Computing Science, University of Glasgow, Glasgow, UK.
Rowland R KaoRoyal (Dick) School of Veterinary Studies and the Roslin Institute, University of Edinburgh, Midlothian, UK. Electronic address: rowland.kao@ed.ac.uk.

Funding

Wellcome Trust 209818/Z/17/Z
6 · The paper itself

Abstract

The proportion of SARS-CoV-2 infections ascertained through healthcare and community testing is generally unknown and expected to vary depending on natural factors and changes in test-seeking behaviour. Here we use population surveillance data and reported daily case numbers in the United Kingdom to estimate the rate of case ascertainment. We mathematically describe the relationship between the ascertainment rate, the daily number of reported cases, population prevalence, and the sensitivity of PCR and Lateral Flow tests as a function time since exposure. Applying this model to the data, we estimate that 20%-40% of SARS-CoV-2 infections in the UK were ascertained with a positive test with results varying by time and region. Cases of the Alpha variant were ascertained at a higher rate than the wild type variants circulating in the early pandemic, and higher again for the Delta variant and Omicron BA.1 sub-lineage, but lower for the BA.2 sub-lineage. Case ascertainment was higher in adults than in children. We further estimate the daily number of infections and compare this to mortality data to estimate that the infection fatality rate increased by a factor of 3 during the period dominated by the Alpha variant, and declined in line with the distribution of vaccines. This manuscript was submitted as part of a theme issue on "Modelling COVID-19 and Preparedness for Future Pandemics".

Indexed as

COVID-19AdultChildDelivery of Health CareHumansSARS-CoV-2United KingdomAscertainment rateInfection fatality rateSARS-CoV-2

Identifiers

PMID36347306
PMCPMC9636607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.